Michael Powell insider trades: Vera Therapeutics (VERA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
and 26 more companies
Open-market buys and sales
52 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2021 | VERA | ↑ Buy | 727,272 | $11.00 | $8.0M | Direct | May 18, 2021 (0d) |
| Feb 9, 2021 | BOLT | ↑ Buy | 450,000 | $20.00 | $9.0M | Direct | Feb 9, 2021 (0d) |
| Aug 11, 2020 | CMPI | ↑ Buy | 133,333 | $15.00 | $2.0M | Indirect | Aug 12, 2020 (1d) |
| Jul 28, 2020 | INZY | ↑ Buy | 437,500 | $16.00 | $7.0M | Direct | Jul 28, 2020 (0d) |
| Jun 30, 2020 | AKUS | ↑ Buy | 58,823 | $17.00 | $1000K | Direct | Jul 1, 2020 (1d) |
| Jun 2, 2020 | ITRM | ↓ Sell | 500,000 | $1.62 | $812K | Direct | Jun 3, 2020 (1d) |
| Nov 15, 2019 | NXTC | ↑ Buy | 150,000 | $36.75 | $5.5M | Direct | Nov 19, 2019 (4d) |
| Nov 12, 2019 | GRTX | ↑ Buy | 750,000 | $12.00 | $9.0M | Direct | Nov 12, 2019 (0d) |
| May 13, 2019 | NXTC | ↑ Buy | 400,000 | $15.00 | $6.0M | Direct | May 15, 2019 (2d) |
| Sep 28, 2018 | ETTX | ↑ Buy | 337,724 | $15.00 | $5.1M | Direct | Oct 2, 2018 (4d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 270,000 | $17.00 | $4.6M | Direct | Sep 20, 2018 (2d) |
| May 30, 2018 | ITRM | ↑ Buy | 500,000 | $13.00 | $6.5M | Direct | May 30, 2018 (0d) |
| Oct 20, 2016 | MRNS | ↓ Sell | 750,683 | $1.39 | $1.0M | Indirect | Oct 24, 2016 (4d) |
| Sep 12, 2016 | OCRX | ↓ Sell | 6,512 | $2.29 | $15K | Indirect | Dec 30, 2016 (109d) |
| Oct 13, 2015 | ACRS | ↑ Buy | 409,090 | $11.00 | $4.5M | Direct | Oct 13, 2015 (0d) |
| Oct 6, 2015 | MIRN | ↑ Buy | 857,142 | $7.00 | $6.0M | Indirect | Oct 6, 2015 (0d) |
| May 12, 2015 | LIFE | ↑ Buy | 320,000 | $14.00 | $4.5M | Direct | May 14, 2015 (2d) |
| Dec 8, 2014 | HSGX | ↑ Buy | 500,198 | $11.00 | $5.5M | Indirect | Dec 10, 2014 (2d) |
| Dec 8, 2014 | HSGX | ↓ Sell | 1,002 | $11.00 | $11K | Indirect | Dec 10, 2014 (2d) |
| Aug 5, 2014 | MRNS | ↑ Buy | 750,683 | $8.00 | $6.0M | Indirect | Aug 7, 2014 (2d) |
| Jul 10, 2014 | AERI | ↓ Sell | 1,008,022 | $24.02 | $24.2M | Direct | Jul 11, 2014 (1d) |
| Jun 4, 2014 | HPTX | ↓ Sell | 417,747 | $27.70 | $11.6M | Direct | Jun 6, 2014 (2d) |
| May 22, 2014 | AERI | ↓ Sell | 323,932 | $16.00 | $5.2M | Indirect | May 27, 2014 (5d) |
| Mar 26, 2014 | VSAR | ↑ Buy | 60,000 | $21.00 | $1.3M | Direct | Mar 28, 2014 (2d) |
| Mar 4, 2014 | HPTX | ↓ Sell | 23,625 | $30.02 | $709K | Indirect | Mar 5, 2014 (1d) |
| Oct 25, 2013 | AERI | ↑ Buy | 285,000 | $10.00 | $2.9M | Indirect | Oct 30, 2013 (5d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 391,166 | $6.03 | $2.4M | Indirect | Jul 17, 2013 (2d) |
| Jul 31, 2012 | HPTX | ↑ Buy | 563,000 | $10.00 | $5.6M | Indirect | Aug 2, 2012 (2d) |
| Jul 24, 2012 | DRTX | ↑ Buy | 588,236 | $9.00 | $5.3M | Indirect | Jul 25, 2012 (1d) |
| Jan 19, 2012 | TSRX | ↓ Sell | 6,900 | $5.59 | $39K | Indirect | Jan 20, 2012 (1d) |
| Jan 17, 2012 | TSRX | ↓ Sell | 24,622 | $5.44 | $134K | Indirect | Jan 17, 2012 (0d) |
| Dec 30, 2011 | ANTH | ↓ Sell | 25,000 | $6.22 | $156K | Direct | Jan 3, 2012 (4d) |
| Dec 22, 2011 | ANTH | ↓ Sell | 50,000 | $6.37 | $318K | Direct | Dec 23, 2011 (1d) |
| Mar 29, 2011 | AMRN | ↓ Sell | 424,900 | $7.25 | $3.1M | Direct | Mar 31, 2011 (2d) |
| Mar 25, 2011 | AMRN | ↓ Sell | 575,100 | $7.55 | $4.3M | Direct | Mar 28, 2011 (3d) |
| Mar 11, 2011 | AMRN | ↓ Sell | 2,000,000 | $7.50 | $15.0M | Direct | Mar 14, 2011 (3d) |
| Mar 10, 2011 | AMRN | ↓ Sell | 637,000 | $7.26 | $4.6M | Direct | Mar 11, 2011 (1d) |
| Feb 25, 2011 | AMRN | ↓ Sell | 363,000 | $8.13 | $3.0M | Direct | Mar 1, 2011 (4d) |
| Dec 23, 2010 | OREX | ↓ Sell | 825,000 | $8.29 | $6.8M | Indirect | Dec 23, 2010 (0d) |
| Dec 20, 2010 | OREX | ↓ Sell | 456,254 | $8.58 | $3.9M | Indirect | Dec 21, 2010 (1d) |
| Aug 6, 2010 | TSRX | ↑ Buy | 830,000 | $5.00 | $4.2M | Indirect | Aug 10, 2010 (4d) |
| Mar 19, 2010 | OREX | ↓ Sell | 700,000 | $6.13 | $4.3M | Indirect | Mar 19, 2010 (0d) |
| Sep 10, 2009 | OREX | ↓ Sell | 400,000 | $9.18 | $3.7M | Indirect | Sep 11, 2009 (1d) |
| Aug 12, 2009 | OREX | ↓ Sell | 400,000 | $8.00 | $3.2M | Indirect | Aug 13, 2009 (1d) |
| Aug 29, 2008 | OREX | ↓ Sell | 700 | $12.09 | $8K | Indirect | Sep 2, 2008 (4d) |
| Aug 28, 2008 | OREX | ↓ Sell | 30,800 | $12.05 | $371K | Indirect | Aug 29, 2008 (1d) |
| Aug 25, 2008 | OREX | ↓ Sell | 10,100 | $12.00 | $121K | Indirect | Aug 25, 2008 (0d) |
| Dec 18, 2007 | ANSV | ↑ Buy | 3,703,704 | $4.05 | $15.0M | Sofinnova Venture Partners VII, LP | Dec 18, 2007 (0d) |
| Aug 15, 2006 | ANSV | ↑ Buy | 1 | $6.86 | $7 | Direct | Aug 16, 2006 (1d) |
| May 15, 2006 | NOVC | ↑ Buy | 391,030 | $6.50 | $2.5M | By SVP | May 15, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VERA insiders
Open-market trades in the last 12 months
About Michael Powell's insider trades
Michael Powell is a 10% owner of Vera Therapeutics (VERA). Since Mar 16, 2006, Michael has reported 26 open-market purchases worth $129.3M and 26 sales worth $133.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (38 filings), conversions (24 filings), other transactions (12 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.